The UK Court of Appeal does not consider hemp flower with a THC content below 0.2% as ‘a narcotic drug’.
Only 8% products had concentrations within 10% of the advertised strength.
Oxford Cannabinoid Technologies is expanding its research and development into oncology.
Experts say giving GPs the right to prescribe cannabis would help drive down NHS waiting lists.
Volteface and The Medical Cannabis Clinicians Society (MCCS) say they will bring about a new bold strategy to the APPG.
Ministers want to reduce the risk of prescriptions being resold on the illicit market.
Current driving laws are outdated and leave patients at risk of prosecution, according to a new report.
Grow Lab Organics and Cancard are establishing the first ‘community-owned’ medicinal cannabis facility in the UK.
Hemp leaves, when separate from the flower, are now no longer classed as a Novel Food in the EU.
Khiron Life Sciences, the leader in cannabinoid-based medicine in Latin America, is now bringing its flagship medicinal product, the full-spectrum cannabis extract KHIRIOX 12/14, to the...